CN Patent

CN119751518A — 制备马立巴韦的方法

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2025-04-04 · 1y expired

What this patent protects

本发明公开了包含马立巴韦的组合物、提供所述组合物的方法和提供可用于提供马立巴韦的中间体的组合物。

USPTO Abstract

本发明公开了包含马立巴韦的组合物、提供所述组合物的方法和提供可用于提供马立巴韦的中间体的组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN119751518A
Jurisdiction
CN
Classification
—
Expires
2025-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.